CS Paper Radar

A Systematic Evaluation of Molecule Generation Models for De Novo Drug Design: From Benchmarks to Practical Insights

Xinrui Xu, Xueer Wang, Dan Luo, Sisi Yuan, Xuan Lin

cs.LG ·submitted 2026-09-09 12:23 UTC · v1
publishedbenchmarkcode/data

Abstract

Molecule generation has emerged as a powerful computational tool for de novo drug design, enabling the exploration of chemical space beyond the limits of conventional virtual screening. The field has progressed rapidly, driven by advances in molecular representations, generative architectures, and target-aware modeling strategies. However, existing reviews typically address specific model families or application scenarios in isolation, rather than offering an integrated perspective on how these components collectively form a coherent generation workflow. In this review, we present a comprehensive evaluation of molecule generation models for de novo drug design, covering 82 methods across five deep generative frameworks, including recurrent neural network (RNN)- and Transformer-based models, variational autoencoders (VAEs), generative adversarial networks (GANs), flow-based models, and diffusion models. We first summarize widely used benchmarks and molecular representations, and then examine the methodological principles underlying both general and pocket-conditioned generation. A central contribution of this work is a systematic synthesis and comparative analysis of reported performance across commonly used benchmarks and evaluation metrics. We also summarize representative experimentally validated case studies. Looking ahead, we discuss future directions in standardized 3D data, interaction-aware generation, receptor flexibility, and multi-objective molecular design, with the aim of improving the reliability and experimental relevance of molecule generation. All collected benchmark resources, evaluation metrics, and model references are provided in a publicly accessible repository at https://github.com/JacklinGroup/molecule-generation-review.

Comment
This document is the unedited Author's version of a Submitted Manuscript subsequently accepted for publication in [Journal of Chemical Information and Modeling]. To access the final published article

Closest papers

Nearest neighbours by meaning across the whole index.

On the Selectivity of Generative Models in Structure-Based Drug Design

cs.LG cs.AI ·2026-10-16 ·Ella Miray Rajaonson, Jungyoon Lee, William Chau, Alan Aspuru-Guzik, Benjamin Sanchez-Lengeling +3 more
top venuebenchmarkcode/data similarity 0.74
Abstract · Accepted as a Presentation at the Neural Information Processing Systems 2026

Designing small-molecule drugs that selectively bind to a target protein while avoiding unintended interactions with other proteins is essential for reducing side effects that contribute substantially to clinical attrition. Although structure-based drug design (SBDD) has advanced rapidly with deep learning, most generative models still optimize binding to a single target and disregard selectivity due to limited training data and unknown off-target interactions. Motivated by this gap, we introduce SELECTBENCH, a comprehensive benchmark assessing the selectivity of generative SBDD models. SELECTBENCH provides three curated evaluation tasks reflecting different real-world drug discovery scenarios: literature-based case studies, safety screening panels used in pharmaceutical development, and large-scale structure-based evaluation sets. We further introduce a suite of metrics to quantify selectivity and conduct a systematic evaluation of nine representative SBDD models, including methods explicitly trained for selectivity and widely-used inference-time guidance techniques. Our results show that even selectivity-trained models achieve only modest off-target discrimination and inference-time guidance provides limited gains, underscoring the need for method improvement. SELECTBENCH provides both a characterization of where current generative SBDD stands on selectivity and an open, extensible platform to accelerate progress. The benchmark is available at https://github.com/lovetaro/selectbench.

0.44

Conditional GraphGANFed: Optimizing Graph-Structured Molecule Generation in Federated Generative Adversarial Networks

cs.LG cs.DC ·2026-08-24 ·Daniel Manu, Abee Alazzwi
published similarity 0.72
Abstract · 10 pages, 3 figures

Generative adversarial networks (GANs) have garnered considerable attention in molecular discovery for their ability to generate novel and high-quality molecules. To efficiently train a GAN model while preserving data privacy, GraphGANFed has been proposed to incorporate federated learning and graph convolutional networks into GAN. Yet, GraphGANFed cannot produce synthetic molecules that only optimize a user-defined metric(s) to facilitate the new drug discovery process. To address this issue, we introduce a novel extension to GraphGANFed, namely conditional GraphGANFed (cGraphGANFed), by incorporating the critic network to assess generated molecules using user-defined metric(s). The evaluation results from both the critic network and discriminator are integrated into the loss function of the generator, guiding it to generate novel molecules that maintain similar chemical properties to real ones while optimizing user-defined metrics. Extensive simulations are conducted in two scenarios. First, cGraphGANFed endeavors to optimize all seven commonly used metrics, and the results show that cGraphGANFed significantly outperforms GraphGANFed in Validity and LogP, with a slight advantage in QED, across different settings. Second, cGraphGANFed focuses solely on optimizing QED, and the results show that the synthetic molecules produced by cGraphGANFed can achieve more than 10% improvement in QED than GraphGANFed. Also, the results demonstrate cGraphGANFed has enhanced resilience against mode collapses and performance reduction caused by non-IID data.

0.26

One Sequence, Many Decodings: CAGenMol-2 Recasts Drug Design as Masked Molecular Inference

cs.LG cs.AI ·2026-09-28 ·Yanting Li, Enyan Dai, Lei Wang, Wen-Cai Ye, Li Liu
similarity 0.72
Abstract

Drug design couples property evaluation, conditional generation, structure-based design, and local optimization, yet machine learning systems typically address these capabilities with separate task-specific models. We introduce CAGenMol-2, a masked diffusion molecular language model that represents molecules, continuous scalar properties, and 3D protein pockets within a single wrapped sequence. Within this pretrained interface, downstream operations are selected by which sequence regions are observed or masked at inference, allowing one checkpoint to perform property prediction, property- and pocket-conditioned generation, and partial-constraint design without task-specific architectures or backbone fine-tuning. We further propose Adaptive Fragment Optimization (AdaFO), a gradient-free mask-and-refill search that turns the masked decoder into an iterative local molecular optimizer. On CrossDocked2020, AdaFO increases Success Rate from 30.2\% to 70.8\%, the best reported under this protocol, while largely preserving drug-likeness and diversity. Finally, scaffold-preserving directional editing and CRBN/VHL case studies demonstrate its use in compound design workflows spanning local molecular editing, structure-based prioritization, and downstream simulation-based screening.

0.15

Classifier-Guided Latent Diffusion for Small-Molecule Generation

cs.LG ·2026-11-13 ·Ali Forooghi, Luis Rueda, Alioune Ngom
similarity 0.70
Abstract

Diffusion models have emerged as a promising class of generative models for molecular design because of their ability to learn complex chemical distributions and support conditional or guided generation. In this work, we investigate a latent diffusion pipeline for property-guided small-molecule generation. The proposed framework represents canonicalized SMILES strings using a frozen ChemBERTa encoder, trains a Transformer-based decoder to reconstruct SELFIES strings from molecular latent embeddings, and learns an unconditional denoising diffusion model in the ChemBERTa latent space. To enable property-directed generation, a differentiable latent property predictor is used to guide the diffusion sampling process. Generated SELFIES strings are converted to SMILES, validated using RDKit, and evaluated using molecular validity, uniqueness, novelty, and predicted property scores. We study guidance toward two drug-relevant binary endpoints: blood--brain barrier permeability and inhibition of human $β$-secretase 1. The results suggest that latent diffusion over pretrained molecular embeddings can generate chemically valid and novel molecules while enabling controllable steering toward desired molecular properties.

0.09

NEAT-POCKET: Pocket-Conditioned Autoregressive 3D Molecular Generation with a Neighborhood-Guided Set Transformer

cs.LG cs.AI ·2026-09-04 ·Roxane Axel Jacob, Daniel Rose, Thierry Langer, Johannes Kirchmair
similarity 0.68
Abstract

AI-driven de novo molecular design offers a promising route to accelerate early-stage drug discovery by generating novel ligands directly within target protein binding pockets. We present NEAT-POCKET, a pocket-conditioned extension of the autoregressive NEAT model for 3D molecular generation. NEAT-POCKET generates molecules atom by atom in protein pocket environments while preserving atom permutation invariance and explicitly modeling hydrogen atoms. Benchmarks on the CrossDocked and SPINDR datasets show that NEAT-POCKET achieves competitive structure-based generation performance while sampling substantially faster than existing baselines. Beyond full-molecule generation, NEAT-POCKET naturally enables pocket-conditioned fragment completion, a task directly relevant to lead optimization and scaffold elaboration. These results position NEAT-POCKET as a fast, flexible, and practical framework for structure-based drug design.

0.20

Controllable Molecule Generation via Sparse Representation Editing: An Interpretability-Driven Perspective

cs.LG ·2026-11-06 ·Zhuoran Li, Xu Sun, Chang Wen Chen, Wanyu Lin
code/data similarity 0.68
Abstract

Controllable molecule generation is crucial for diverse scientific applications, such as drug discovery and materials design. While large language models (LLMs) show great promise, their dense and entangled representations impede precise control over the generation of molecules with bespoke substructures or properties. To address this, we propose Sparse Representation Editing (SpaRE), an interpretability-driven framework for fine-grained and precise control in LLM-based molecule generation. The crux of SpaRE is to learn an overcomplete sparse feature space that disentangles LLM representations into a compact set of latent features corresponding to chemically meaningful concepts. Within this space, we can directly manipulate these concept-aligned latent features to achieve (1) local control, by generating target atoms and functional groups at specified positions; and (2) global control, by customizing the overall structural and physicochemical properties within defined ranges. In this way, our framework advances interpretability from post-hoc analysis to actionable generative control. Experiments show that SpaRE can generate chemically desirable molecules under complex constraints in real-world scenarios, while offering mechanistic insights for quantitative structure-property analysis. The code and demo are available at https://github.com/WanyuGroup/ICML2026_SpaRE.

0.38

Interpretable and Steerable Molecular Graph Generation using Concept Bottlenecks

cs.LG ·2026-10-25 ·Sarabeshwar Balaji, Ritesh Kumar, Lav R. Varshney
published similarity 0.68
Abstract · Accepted at AI for Drug Discovery Workshop @ NeurIPS 2026. Additional experiments added

Deep graph generators (DGGs) largely lack interpretability, which is a significant limitation for one of their most crucial applications, drug discovery, where interpretable and transparent generation could provide greater control over the desirability of generated molecules, thereby reducing trial-and-error in candidate selection. Common approaches to interpretability, such as disentanglement, cannot guarantee that the learned representations are human-interpretable. To address this, we propose incorporating concept bottlenecks into DGGs, allowing users to interpret, debug, and steer the generation process. We show that this consistently improves distributional fidelity (lower FCD), with only modest, non-systematic effects on validity and uniqueness. We further explore Concept Controller, an optimization-based steering approach that has proven to be effective for steerable image generation. We evaluate our approach on a one-shot molecular graph generation framework, though the underlying ideas can be transferred to sequential graph generation as well.

0.20

Multi-Objective Generative Optimization via Expected Hypervolume Fine-Tuning

cs.LG ·2026-11-03 ·Juan Guevara, Riccardo De Santi, Andreas Krause, Raul Astudillo
similarity 0.67
Abstract

Scientific discovery requires plausible designs spanning useful trade-offs among competing properties: a molecule with strong binding affinity, for example, may be difficult to synthesize. Pretrained generative models, e.g., flow and diffusion generators, provide a foundation for proposing such designs, but steering them toward high-quality, complementary trade-offs remains challenging. Inference-time search incurs high per-sample costs, while fine-tuning typically relies on fixed per-candidate rewards that do not capture how designs complement one another. We introduce Hypervolume Fine-Tuning (HVFT), which adapts a single pretrained generator to maximize the expected hypervolume of its samples while controlling departure from the pretrained distribution. Expected hypervolume jointly rewards candidate quality and collective trade-off coverage. Nonetheless, we show that it cannot be expressed as the expectation of a fixed per-candidate reward and therefore cannot be optimized directly with standard techniques. A key observation of this work is that its first variation corresponds to the expected marginal hypervolume contribution of a candidate, which yields a tractable adaptive reward via an unbiased estimator based on model samples. HVFT uses this reward to decompose the objective into a sequence of KL-proximal scalar-reward subproblems. We establish concavity, relative smoothness, and convergence guarantees for the resulting distributional procedure. Across therapeutic-peptide and molecular design tasks spanning discrete diffusion and continuous flow-matching models, HVFT achieves state-of-the-art expected hypervolume and trade-off coverage.

0.04